You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0194 A Novel Reversibile Bruton's Tyrosine Kinase (BTK) Inhibitor (BMS-986142) Provides Favorable Safety, Pharmacokinetic, and Pharmacodynamic Profiles in Healthy Subjects

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0194 A Novel Reversibile Bruton's Tyrosine Kinase (BTK) Inhibitor (BMS-986142) Provides Favorable Safety, Pharmacokinetic, and Pharmacodynamic Profiles in Healthy Subjects

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016200
Aug 2016701
Sep 2016402
Oct 20161303
Nov 20162102
Dec 201624030
Jan 20173704
Feb 20173109
Mar 20173003
Apr 20171401
May 20172903
Jun 20174004
Jul 20173801
Aug 20175605
Sep 20174802
Oct 20174206
Nov 20173001
Dec 20173601
Jan 20182000
Feb 20181400
Mar 20183600
Apr 20182800
May 20182602
Jun 20182600
Jul 20181600
Aug 20182600
Sep 2018600
Oct 20181800
Nov 20182001
Dec 20181000
Jan 20193201
Feb 20191200
Mar 20192600
Apr 20192600
May 20192400
Jun 20191201
Jul 20191300
Aug 2019600
Sep 2019600
Oct 20191800
Nov 20191600
Dec 20193700
Jan 20201200
Feb 20202000
Mar 2020800
Apr 2020600
May 2020200
Jun 2020800
Jul 20204202
Aug 2020800
Sep 20202800
Oct 20202801
Nov 20201000
Dec 20201800
Jan 2021800
Feb 2021600
Mar 20211601
Apr 2021600
May 2021300
Sep 2021001
Oct 2021200
Nov 20211600
Dec 2021800
Jan 2022600
Feb 2022400
Mar 2022200
May 20221000
Jun 2022900
Jul 20221000
Aug 20222400
Sep 2022600
Oct 20221600
Nov 20221300
Dec 20221400
Jan 20231200
Feb 20231501
Mar 20231400
Apr 20231100
May 20231300
Jun 2023800
Jul 2023900
Aug 2023600
Sep 20231000
Oct 2023400
Nov 20232601
Dec 2023600
Jan 2024200
Feb 2024801
Mar 2024900
Total1498091